All In Biotech

Free tool

FAERS Monitor: Carafate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018333 or its brand name (Carafate, Sucralfate). Reports on generic versions are filed under their own applications.

Reports

24,155

Serious

16,587

69% of reports

Hospitalization

9,364

Death reported

2,328

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea2,389
  • fatigue1,831
  • diarrhoea1,787
  • pain1,543
  • headache1,453
  • vomiting1,433
  • off label use1,386
  • dyspnoea1,383
  • drug ineffective1,359
  • dizziness1,095
  • abdominal pain1,035
  • weight decreased1,031
  • malaise1,013
  • pneumonia991
  • chronic kidney disease988

Reports by year received

View as table
YearReports
2004252
2005266
2006251
2007265
2008324
2009405
2010543
2011660
2012880
2013727
2014841
20151,422
20161,829
20171,577
20181,878
20192,058
20201,851
20211,461
20221,358
20231,407
20241,322
20251,509
20261,064

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,004 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal98811.510.89,332
abdominal painSignal1,0353.93.72,231
weight decreasedSignal1,0313.23.01,595
pneumoniaSignal9912.72.51,047
vomitingSignal1,4332.72.51,511
nauseaSignal2,3892.62.52,505
diarrhoeaSignal1,7872.42.31,522
painSignal1,5432.22.11,024
dyspnoeaSignal1,3832.12.0849
fatigueSignal1,8312.12.01,020
headacheSignal1,4532.01.9769
malaiseSignal1,0132.01.9526
dizziness1,0951.91.8487
off label use1,3861.41.3150
drug ineffective1,3590.90.917

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.